Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.57 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.57 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.57 |
| ▸ | SGPL1 | O95470 | 4/20 | 0.56 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.56 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.56 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.52 |
| ▸ | FDPS | P14324 | 3/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.51 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.51 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7859707 | 1.00 | LPAR3 (0.57) | LPAR3LPAR1LPAR2SGPL1SMPD1 | |
| SCHEMBL21346930 | 1.00 | LPAR3 (0.57) | LPAR3LPAR1LPAR2SGPL1SMPD1 | |
| SCHEMBL9618051 | 1.00 | LPAR3 (0.57) | LPAR3LPAR1LPAR2SGPL1SMPD1 | |
| SCHEMBL10781130 | 1.00 | LPAR3 (0.57) | LPAR3LPAR1LPAR2SGPL1SMPD1 | |
| SCHEMBL21141423 | 1.00 | LPAR3 (0.57) | LPAR3LPAR1LPAR2SGPL1SMPD1 | |
| SCHEMBL22844447 | 1.00 | LPAR3 (0.57) | LPAR3LPAR1LPAR2SGPL1SMPD1 | |
| SCHEMBL10630367 | 1.00 | LPAR3 (0.57) | LPAR3LPAR1LPAR2SGPL1SMPD1 | |
| SCHEMBL10781198 | 1.00 | LPAR3 (0.57) | LPAR3LPAR1LPAR2SGPL1SMPD1 | |
| SCHEMBL9632719 | 1.00 | LPAR3 (0.57) | LPAR3LPAR1LPAR2SGPL1SMPD1 | |
| SCHEMBL9615790 | 1.00 | LPAR3 (0.57) | LPAR3LPAR1LPAR2SGPL1SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630438-B2 | Process for producing precipitated calcium carbonate in the presence of natural ground calcium carbonate | OMYA INTERNATIONAL AG (CH) | 2026-05-19 | — | — | US | disclosed |
| US-12486379-B2 | Use of a porous filler for reducing the gas permeability of an elastomer composition | OMYA INTERNATIONAL AG (CH) | 2025-12-02 | — | — | US | disclosed |
| US-20250051539-A1 | CALCIUM CARBONATE-COMPRISING MATERIAL WITH HIGH BIO-BASED CARBON CONTENT FOR POLYMER FORMULATIONS | OMYA INTERNATIONAL AG (CH) | 2025-02-13 | — | — | US | disclosed |
| US-20240409719-A1 | PRECIPITATED CALCIUM CARBONATE WITH HIGH BIO-BASED CARBON CONTENT FOR POLYMER FORMULATIONS | OMYA INTERNATIONAL AG (CH) | 2024-12-12 | — | — | US | disclosed |
| EP-4452858-A1 | CALCIUM CARBONATE-COMPRISING MATERIAL WITH HIGH BIO-BASED CARBON CONTENT FOR POLYMER FORMULATIONS | Omya International AG (CH) | 2024-10-30 | — | — | EP | disclosed |
| EP-4453100-A1 | PRECIPITATED CALCIUM CARBONATE WITH HIGH BIO-BASED CARBON CONTENT FOR POLYMER FORMULATIONS | Omya International AG (CH) | 2024-10-30 | — | — | EP | disclosed |
| CN-118414307-A | Calcium carbonate-containing material with high bio-based carbon content for polymer formulations | OMYA国际股份公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-118414387-A | Precipitated calcium carbonate with high bio-based carbon content for polymer formulations | OMYA国际股份公司 | 2024-07-30 | — | — | CN | disclosed |
| US-12024825-B2 | Methods for verifying the authenticity of products | OMYA INTERNATIONAL AG (CH) | 2024-07-02 | — | — | US | disclosed |
| US-11873387-B2 | Surface-treated fillers for polyester films | OMYA INTERNATIONAL AG (CH) | 2024-01-16 | — | — | US | disclosed |
| EP-2952543-A1 | Polymer composition filled with an inorganic filler material mixture | Omya International AG (CH) | 2015-12-09 | — | — | EP | disclosed |
| WO-2015181037-A1 | PROCESS FOR THE PREPARATION OF CRUMBLES COMPRISING CALCIUM CARBONATE | OMYA INTERNATIONAL AG (CH) | 2015-12-03 | — | — | WO | disclosed |
| EP-2949813-A1 | Process for preparing a surface-modified material | Omya International AG (CH) | 2015-12-02 | — | — | EP | disclosed |
| EP-2949707-A1 | Process for the preparation of crumbs comprising calcium carbonate | Omya International AG (CH) | 2015-12-02 | — | — | EP | disclosed |
| CN-105073864-A | New surface treatment of white mineral materials for application in plastics | OMYA INT AG | 2015-11-18 | — | — | CN | disclosed |
| EP-2770017-B1 | New surface treatment of white mineral materials for application in plastics | OMYA INT AG (CH) | 2015-09-02 | — | — | EP | disclosed |
| WO-2015028280-A1 | EARTH ALKALI CARBONATE, SURFACE MODIFIED BY AT LEAST ONE POLYHYDROGENSILOXANE | OMYA INTERNATIONAL AG (CH) | 2015-03-05 | — | — | WO | disclosed |
| EP-2843005-A1 | Earth alkali carbonate, surface modified by at least one polyhydrogensiloxane | Omya International AG (CH) | 2015-03-04 | — | — | EP | disclosed |
| WO-2014128087-A1 | NEW SURFACE TREATMENT OF WHITE MINERAL MATERIALS FOR APPLICATION IN PLASTICS | OMYA INTERNATIONAL AG (CH) | 2014-08-28 | — | — | WO | disclosed |
| EP-2770017-A1 | New surface treatment of white mineral materials for application in plastics | Omya International AG (CH) | 2014-08-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630438-B2 | Process for producing precipitated calcium carbonate in the presence of natural ground calcium carbonate | TMCO1, CALCOCO2, CACNA2D1 | LPAR3 2024/4885LPAR1 2215/4885LPAR2 1963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.